Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Moores Cancer Center at UC San Diego Health, La Jolla, California California Cancer Associates for Research & Excellence, Inc., San Marcos, California Vanderbilt-Ingram Cancer Ctr, Nashville, Tennessee Canada
BC Cancer Vancouver Centre, Vancouver, British Columbia Princess Margaret Cancer Center, Toronto, Ontario Jewish General Hospital, Montreal, Quebec South Korea
Seoul National University Hospital, Seoul Samsung Medical Center, Seoul